Julia P. Dunn

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Atul Malhotra, Ronald R. Grunstein, Ingo Fietze et al. · New England Journal of Medicine · 2024 · 648 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Louis J. Aronne, Deborah B. Horn, Carel W. le Roux et al. · New England Journal of Medicine · 2025 · 418 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery

James M. Isbell, Robyn A. Tamboli, Erik N. Hansen et al. · Diabetes Care · 2010 · 251 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17